Clinical Trials Browser

OTHER_GOV × Stomach Neoplasms × Immune Checkpoint Inhibitors × Clear all

NCT04891900 2024-07-08

TQB2450 Plus Anlotinib Combined With Chemotherapy in the Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma

Phase NA Active not recruiting

Gastrointestinal

Stomach Neoplasms